Quintessence International
Login:
username:

password:

Plattform:

Forgotten password?

Registration

Quintessence Int 45 (2014), No. 3     24. Jan. 2014
Quintessence Int 45 (2014), No. 3  (24.01.2014)

Page 239-243, doi:10.3290/j.qi.a31204, PubMed:24570991


Management of third molar removal with doses of native plasma-derived factor IX (Octanine) and local measures in a female patient with severe hemophilia B: A case report
Peisker, Andre / Kentouche, Karim / Raschke, Gregor Franziskus / Schultze-Mosgau, Stefan
Patients with hemophilia are at high risk of bleeding following oral surgery. As an X-linked recessive chromosomal bleeding disorder it is very rare in female patients. This is the first described case of management of third molar removal in a female patient suffering from severe hemophilia B. Excellent hemostasis was achieved by following a protocol using defined pre- and postoperative doses of factor IX and local hemostatic measures of collagen fleece, fibrin glue, primary suture, and tranexamic acid solution. Following defined protocols is essential in the management of oral surgery in patients with hemophilia and helps to prevent postoperative hemorrhages.

Keywords: bleeding disorder, factor replacement, female patient, hemophilia B, local measures, third molar removal
fulltext (no access granted) order article as PDF-file (20.00 €)